G7 nations have committed to donating one billion vaccine doses to low-income countries, signaling a major step in international solidarity. Experts agree that only widespread global vaccination can fully end the pandemic, requiring cooperation across borders.
With more than 2 billion doses administered worldwide, COVID-19 is stabilizing in wealthier nations. As the G7 summit kicks off in Carbis Bay, UK—from June 11 to 13—leaders are prioritizing unequal vaccine access. This is critical, as variants emerging in under-vaccinated regions threaten global recovery.
The COVAX initiative, backed by the Vaccine Alliance, WHO, and CEPI, has delivered over 80 million doses to 129 countries. Yet some nations are acting independently. China, now the world's leading vaccine producer surpassing India, has redirected output abroad after controlling its outbreak. Beijing has supplied 231 million doses of Sinovac, Sinopharm, and CanSino vaccines, aiming for 700 million exports—especially to Africa and 27 countries approving Sinopharm. Donations, though a smaller share, aid Asia and Africa significantly, per Asialyst reports.
French President Emmanuel Macron urged a global push to vaccinate Africa during his South Africa visit, emphasizing local supply. The UAE, partnering with Sinopharm, is building a facility to produce 200 million doses annually for disadvantaged nations, particularly in Africa.
Other sites include Pfizer packaging in Belgium, France, and Switzerland; Moderna's vaccine at Rovi in Madrid, Spain; and Sputnik V in Kazakhstan and Serbia. Last May, U.S. President Joe Biden backed waiving vaccine patents, echoed by leaders like Macron. The prior G7 agreed to fund African campaigns against vaccine inequity. India's export halt—the "world's pharmacy"—caused shortages, but improving conditions may restore its role.
